Burc Barin

2.6k total citations
32 papers, 723 citations indexed

About

Burc Barin is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Burc Barin has authored 32 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 11 papers in Epidemiology and 10 papers in Hepatology. Recurrent topics in Burc Barin's work include HIV/AIDS drug development and treatment (10 papers), HIV/AIDS Research and Interventions (9 papers) and Hepatitis C virus research (9 papers). Burc Barin is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), HIV/AIDS Research and Interventions (9 papers) and Hepatitis C virus research (9 papers). Burc Barin collaborates with scholars based in United States, United Kingdom and Cyprus. Burc Barin's co-authors include Peter G. Stock, Michelle E. Roland, Frances Priddy, Jessica E. Haberer, David R. Bangsberg, Omu Anzala, James F. Rooney, David H. Mark, Paramesh Chetty and Patricia Fast and has published in prestigious journals such as Blood, Gastroenterology and PLoS ONE.

In The Last Decade

Burc Barin

32 papers receiving 708 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Burc Barin United States	15	514	364	138	131	96	32	723
Knud Schewe Germany	19	867 1.7×	546 1.5×	350 2.5×	11 0.1×	300 3.1×	47	1.2k
Clifton A. Hawkes United States	10	340 0.7×	292 0.8×	28 0.2×	104 0.8×	246 2.6×	14	626
Aza Rakhmanova Russia	16	789 1.5×	332 0.9×	71 0.5×	10 0.1×	572 6.0×	42	977
Diego Ripamonti Italy	21	969 1.9×	358 1.0×	155 1.1×	12 0.1×	630 6.6×	62	1.2k
Lisette Johnson United States	9	664 1.3×	1.2k 3.3×	811 5.9×	8 0.1×	195 2.0×	9	1.6k
Tengiz Tsertsvadze Georgia	19	457 0.9×	861 2.4×	615 4.5×	4 0.0×	108 1.1×	98	1.1k
Emmanuel Fajardo Switzerland	13	324 0.6×	263 0.7×	178 1.3×	9 0.1×	163 1.7×	29	518
Laura G. Wesolowski United States	16	713 1.4×	590 1.6×	312 2.3×	5 0.0×	532 5.5×	44	1.1k
Mallory D. Witt United States	14	424 0.8×	454 1.2×	154 1.1×	4 0.0×	161 1.7×	25	827
Meighan Krows United States	13	592 1.2×	585 1.6×	192 1.4×	3 0.0×	155 1.6×	26	861

Countries citing papers authored by Burc Barin

Since Specialization

Citations

This map shows the geographic impact of Burc Barin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burc Barin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burc Barin more than expected).

Fields of papers citing papers by Burc Barin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burc Barin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burc Barin. The network helps show where Burc Barin may publish in the future.

Co-authorship network of co-authors of Burc Barin

This figure shows the co-authorship network connecting the top 25 collaborators of Burc Barin. A scholar is included among the top collaborators of Burc Barin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burc Barin. Burc Barin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barin, Burc, et al.. (2022). Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study. The Lancet Microbe. 3(4). e274–e283. 53 indexed citations

Millar, Eugene V., Jason W. Bennett, Burc Barin, et al.. (2021). Safety, immunogenicity, and efficacy of NDV-3A against Staphylococcus aureus colonization: A phase 2 vaccine trial among US Army Infantry trainees. Vaccine. 39(23). 3179–3188. 11 indexed citations

Barin, Burc, et al.. (2021). Joint Investigation of 2-Month Post-diagnosis IgG Antibody Levels and Psychological Measures for Assessing Longer Term Multi-Faceted Recovery Among COVID-19 Cases in Northern Cyprus. Frontiers in Public Health. 8. 590096–590096. 5 indexed citations

Karaderi, Tugce, Deniz Balcı, Burc Barin, et al.. (2020). Host Genetics at the Intersection of Autoimmunity and COVID-19: A Potential Key for Heterogeneous COVID-19 Severity. Frontiers in Immunology. 11. 586111–586111. 24 indexed citations

Hocaoğlu, Mevhibe, Tugce Karaderi, Bahar Taneri, et al.. (2019). Cyprus Women’s Health Research (COHERE) initiative: determining the relative burden of women’s health conditions and related co-morbidities in an Eastern Mediterranean population. BMC Women s Health. 19(1). 50–50. 4 indexed citations

Barin, Burc, et al.. (2017). Impact of Genetic Defects on Coronary Atherosclerosis among Turkish Cypriots. The Heart Surgery Forum. 20(5). 223–223. 3 indexed citations

Brooks, W. Abdullah, Khalil Zaman, Kristen Lewis, et al.. (2016). Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial. The Lancet Global Health. 4(12). e946–e954. 47 indexed citations

Roland, Michelle E., Burc Barin, Shirish Huprikar, et al.. (2015). Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls. AIDS. 30(3). 1–1. 52 indexed citations

Balagopal, Ashwin, et al.. (2015). Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected Persons. PLoS ONE. 10(8). e0135882–e0135882. 3 indexed citations

10.

Mutua, Gaudensia, Juliet Mpendo, William Kilembe, et al.. (2014). Major Negative Social Impacts Are Rare in Phase 1 HIV Vaccine Trials in Africa. AIDS Research and Human Retroviruses. 30(S1). A190–A191. 2 indexed citations

11.

Omosa-Manyonyi, Gloria, Gaudensia Mutua, Bashir Farah, et al.. (2014). Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya. PLoS ONE. 9(10). e110228–e110228. 4 indexed citations

12.

Stock, Peter G., Burc Barin, Hiroyu Hatano, et al.. (2014). Reduction of HIV Persistence Following Transplantation in HIV-Infected Kidney Transplant Recipients. American Journal of Transplantation. 14(5). 1136–1141. 53 indexed citations

13.

Mugo, Peter, Eduard J. Sanders, Gaudensia Mutua, et al.. (2014). Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya. AIDS and Behavior. 19(5). 794–801. 38 indexed citations

14.

Ansari, Israr-ul H., Todd M. Allen, Andrew Berical, et al.. (2013). Phenotypic analysis of NS5A variant from liver transplant patient with increased cyclosporine susceptibility. Virology. 436(2). 268–273. 6 indexed citations

15.

Kibengo, Freddie, Eugene Ruzagira, David Katende, et al.. (2013). Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial. PLoS ONE. 8(9). e74314–e74314. 67 indexed citations

16.

Branch, Andrea D., Burc Barin, Adeeb Rahman, Peter G. Stock, & Thomas D. Schiano. (2013). Vitamin D Status of Human Immunodeficiency Virus–Positive Patients With Advanced Liver Disease Enrolled in the Solid Organ Transplantation in HIV: Multi-Site Study. Liver Transplantation. 20(2). 156–164. 4 indexed citations

17.

Bahirwani, Ranjeeta, Burc Barin, Kim M. Olthoff, et al.. (2013). Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus–coinfected recipients versus human immunodeficiency virus–infected recipients without hepatitis C virus: Results from the national institutes of health multi-site study. Liver Transplantation. 19(6). 619–626. 6 indexed citations

18.

Mutua, Gaudensia, Eduard J. Sanders, Peter Mugo, et al.. (2012). Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers. PLoS ONE. 7(4). e33103–e33103. 133 indexed citations

19.

Nissen, Nicholas N., Burc Barin, & Peter G. Stock. (2012). Malignancy in the HIV-infected patients undergoing liver and kidney transplantation. Current Opinion in Oncology. 24(5). 517–521. 20 indexed citations

20.

Subramanian, Aruna, Mark Sulkowski, Burc Barin, et al.. (2009). MELD Score Is an Important Predictor of Pretransplantation Mortality in HIV-Infected Liver Transplant Candidates. Gastroenterology. 138(1). 159–164. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact